The biological substrate of the Motoric Cognitive Risk syndrome: a pilot study using Amyloid-/Tau-PET and MR imaging

Manuscript Number: 

21-5461R3

Author(s): 
Gilles Allali, Stéphane Armand, Frédéric Assal, Giulia Bommarito, Giovanni B. Frisoni, Valentina Garibotto, Alessandra Griffa, Federica Ribaldi, Sara Stampacchia

Disclosures

Gilles Allali

  • Nothing to Disclose

Stéphane Armand

  • Nothing to Disclose

Frédéric Assal

  • Nothing to Disclose

Giulia Bommarito

  • Nothing to Disclose

Giovanni B. Frisoni

  • Consulting Fees:
    From a number of pharma companies in the field of drug development for Alzheimer's disease
    Lecture Fees:
    From a number of pharma companies in the field of drug development for Alzheimer's disease

Valentina Garibotto

  • Lecture Fees:
    GE Healthcare, Siemens, Roche, Cerveau, Merck

Alessandra Griffa

  • Nothing to Disclose

Federica Ribaldi

  • Nothing to Disclose

Sara Stampacchia

  • Nothing to Disclose